Subjects' Views of Obligations to Ensure Post-Trial Access to Drugs, Care, and Information: Qualitative Results from the Experiences of Participants in Clinical Trials (EPIC) Study

N. Sofaer, C. Thiessen, S.D. Goold, J. Ballou, K.A. Getz, G. Koski, R.A. Krueger and J.S. Weissman

Mathematica Policy Research Reports from Mathematica Policy Research

Abstract: There is increasing interest in the question of what, if anything, research subjects are owed after their participation in a clinical trial ends. This article reports on 93 individuals who participated in 10 focus groups.

Keywords: Health Care; EPIC; Experiences of Participants in Clinical Trials (search for similar items in EconPapers)
Pages: 6
References: Add references at CitEc
Citations:

Downloads: (external link)
http://jme.bmj.com/cgi/content/abstract/35/3/183 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:mpr:mprres:a9ef010ba94f458cab7e5f2529f5e756

Access Statistics for this paper

More papers in Mathematica Policy Research Reports from Mathematica Policy Research Mathematica Policy Research P.O. Box 2393 Princeton, NJ 08543-2393 Attn: Communications. Contact information at EDIRC.
Bibliographic data for series maintained by Joanne Pfleiderer () and Cindy George ( this e-mail address is bad, please contact ).